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Evolution of endoscopic surgery in the treatment of inverted 
papilloma
Abstract
Fábio de Azevedo Caparroz1, Luciano Lobato Gregório2, Eduardo Macoto Kosugi3
Inverted papilloma (IP) has several treatment avenues. The endoscopic approach in the last decade 
has proven to be a good option over the traditional approach.
Objective: Describe the epidemiological profile of patients with inverted Papilloma, describe our 
experience on managing this tumor and compare our data with the literature. Study Design: Cross-
sectional, historical cohort.
Method: Retrospective study of medical records of 17 patients treated for histopathologically-
confirmed inverted papilloma between 2005 and 2011. We assessed patients age, gender, tumor side, 
symptoms, diagnosis, comorbidities and habits, Krouse staging, surgical approach, intraoperative and 
postoperative, and malignant postoperative recurrence and also the correlation between recurrence 
with preoperative staging, the surgical approach used, and the presence of malignancy.
Results: Five (29.41%) patients were classified as Krouse stage T2, 9 (52.94%) as T3 and 3 (17.65%) 
as T4. Three (17.65%) patients had malignancy and the recurrence rate was 23.5% (4 pacients). Eleven 
patients (64.70%) underwent endoscopic approach, 3 (17.6%) the combined aprroach (endoscopic 
assisted) and 3 (17.6%) external approach.
Conclusion: The endoscopic approach is currently becoming a method not only effective but also 
safe for the treatment of more advanced stages of IP.
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INTRODUCTION
Inverted papilloma (IP) is a common benign tumor 
of the nose and paranasal sinuses, originating from the 
Schneiderian epithelium of the lateral nasal wall, first 
described in 1854 by Ward1. They make up approximately 
0.5% to 4% of the primary nasal tumors, and are more 
common on the fifth and sixth decades of life, having an 
incidence of 0.5 to 1.5 cases per 100,000 inhabitants. Its 
main characteristics are a tendency to recurrence, local 
aggressiveness and association with malignancy2. They 
may invade the lacrimal system, the orbit, the intracranial 
cavity and cause bone erosion and destruction and that 
of adjacent soft tissue3. The malignization rates in the 
literature vary between 5% and 15%4.
Although the clinical progress is well documented 
in the literature, the etiology of the inverted papilloma is 
uncertain. Recent studies have shown that besides having 
a 33% association with the human papilloma virus (HPV)5, 
there is an increase in the presence of HPV types 16 and 
18 in tumors with severe dysplasia, or even carcinoma6. 
These results show that, maybe, the HPV has an important 
role to play in the etiology of inverted papilloma7.
Diagnosis may be suspected by means of the medi-
cal interview, physical exam and image exam - such as CT 
scan and MRI, but it can only be confirmed by means of 
histology. Krouse3,8,9, and later on, Han et al.4,8 proposed 
classifications which enable comparisons between surgical 
techniques according to tumor staging. The standard tre-
atment initially proposed to resect the inverted papilloma 
was the external access by lateral rhinostomy, described 
by Moure, in 19029. Notwithstanding, this technique has 
complications, both temporary and permanent, such as 
atrophic rhinitis, persistent crusts and purulent rhinorrhea, 
let alone the scar.
In recent years, we have seen the progress in the 
endoscopic-assisted resection of inverted papillomas with 
lower rates of recurrence in relation to the beginning of the 
era of endoscopy9. Moreover, the endoscopic resection is 
done in a minimum, with the same effectiveness to control 
the tumor, thus avoiding the comorbidities of the con-
ventional approach8. The development of the endoscope 
brought about a number of advantages when compared to 
external approaches, such as better view of the operation 
field, less resection of viable tissue not involved by the 
tumor - causing less crust formation, less bleeding and 
less postoperative pain, in other words, reducing mor-
bidity and maintaining the same effectiveness4,9. Today, 
there is a trend of considering the endoscopic technique 
alone as the gold standard to treat most cases of inverted 
papillomas, even in the most advanced stages10, including 
the treatment of recurrences11.
The goal of our study was to discuss a sample of 
patients seen in our department, with a diagnosis of inver-
ted papilloma, confirmed by histopathology, and describe 
our experience in its treatment, comparing the results with 
reports in the national and international literature.
METHOD
Cross-sectional historical cohort study, assessing 
patients seen in a rhinology department with a pathology 
report of inverted papilloma during the period of January 
of 2005 and October of 2011. This study project has been 
submitted to and approved by the Ethics Committee in Re-
search of our Institution, under protocol number # 2079/11. 
Inclusion criteria for the sample were a confirmed histo-
logical diagnosis in the surgical specimen and minimum 
follow up time of 4 months. From an initial sample of 26 
patients, we included 17 with an average follow up time 
of 18.3 months and we took off the patients with follow 
up time of less than 4 months (loss of follow up). All the 
patients were classified according to the classification pro-
posed by Krouse3, based on the CT scan of preoperative 
paranasal sinuses.
We assessed: age, gender, tumor side, symptoms 
upon diagnosis (nasal obstruction, anterior or posterior 
rhinorrhea, epistaxis, hyposmia, cacosmia, headache and 
facial pain), comorbidities and habits, Krouse staging, sur-
gical approach, intra and postoperative complications, ma-
lignization and postoperative recurrence. We also assessed 
the possibility of correlation between the recurrences with 
higher preoperative staging, with the surgical approach 
utilized and the presence of malignization utilizing the 
Pearson’s coefficient. All the patients were submitted to 
surgery by the same team, by external approach, endonasal 
endoscopic or a combined approach. The postoperative 
follow up was carried out by nasal endoscopy in series, 
weekly in the first month and monthly until the sixth 
month. Later on, the follow up was every six months. In 
suspecting clinical recurrence, we carried out a CT scan 
of the paranasal sinuses.
RESULTS
The study included 17 patients, seen between 
January of 2005 and October of 2011. The sample charac-
teristics are seen on Table 1.
The symptoms presented by the patients are des-
cribed on Table 2.
The comorbidities of the patients are listed on Table 3.
The patients were classified according to Krouse’s 
staging system. No patient was classified in stage I; five 
patients (29.41%) in stage II; nine patients (52.94%) in stage 
III; and three patients (17.65%) in stage IV.
Complications and malignization found are descri-
bed on Table 4.
There were four recurrences in our sample, corres-
ponding to 23.5% of the cases. There were no correlations 
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Table 1. Sample characteristics.
Data N %
Gender
Males 14 82.3
Females 3 17.6
Side
Left 8 47.0
Right 9 52.9
Age (years)
Mean 58.76 -
SD 7.42 -
Minimum 47 -
Median 58 -
Maximum 73 -
N: Number; %: percentage.
Table 2. Symptom distribution.
Symptom N %
Nasal obstruction 17 100
Epistaxis 10 58.8
Hyposmia 9 52.9
Anterior rhinorrhea 7 41.1
Headache 6 35.2
Cough 4 23.5
Posterior rhinorrhea 2 11.7
Cacosmia 2 11.7
Facial pain 1 5.8
N: Number; %: percentage.
Table 3. Comorbidities.
Comorbidity N %
Smoking 8 47.0
Hypertension 8 47.0
Alcohol drinking 2 11.7
Coronary failure 2 11.7
Diabetes 1 5.8
Dyslipidemia 1 5.8
N: Number; %: percentage.
Table 4. Complications and malignization.
Characteristics Number %
Intraoperative complication 0 0
Postoperative complication Synechia 1 5.8
Septal perforation 1 5.8
Oroantral fistula 1 5.8
Malignization 3 17.6
%: percentage.
between the recurrences and a higher staging, through 
the endoscopic approach only, or malignization. The dis-
tribution of recurrences according to staging is shown on 
Table 5. Distribution of stages and recurrences.
Stage
Krouse’s stage Recurrence
N (% of cases) N (% of the stage)
I 0 - 0 -
II 5 29.4 1 20
III 9 52.9 2 22.2
IV 3 17.6 1 33.3
Total 17 100 4 23.5
N: Number; %: percentage.
Table 5. Despite the trend shown on the table displaying 
the increase in recurrence with worsening of the staging, 
there were no associations between these two variables 
(Pearson r = 0.05).
The assessment of recurrences according to the 
approach and staging is shown on Table 6. Moreover, 
we can see the number of cases and the approach 
(external, combined or endoscopic) to which the patient 
was submitted to. In 64% of the cases, the approach 
was the endoscopic alone. There were no correlations 
between the recurrences and the approach (r = 0.1) or 
with malignancy (r = 0.1).
DISCUSSION
Sinonasal inverted papilloma is a benign neoplasia 
which can be diagnosed at any age, predominating 
between the fifth and sixth decades of life, and specially 
among males12, and such information was confirmed in 
our study - mean age of 58 years and a predominance 
of males (82.3%). The most commonly found symptoms 
were unilateral nasal obstruction (100% of the cases), 
epistaxis (58.8%), hyposmia and/or anosmia (52.9%), 
anterior rhinorrhea (41.1%) and headaches (35.3%). There 
was a greater incidence of anterior epistaxis (58.8%) upon 
diagnosis, vis-à-vis the literature, which varies between 
6%13 and 20%14, and this is a differential symptom in 
relation to rhinosinusitis. Even then, the low specificity 
of symptoms makes it difficult to distinguish inverted 
papillomas from other sinonasal tumors and it delays the 
diagnosis in many cases. Besides epistaxis, it is worth 
remembering that most signs and symptoms are unilateral, 
which may call the physician’s attention concerning the 
diagnosis of neoplasia12.
As far as staging is concerned, preoperative staging 
based on Krouse’s classification, our findings are in agre-
ement with the literature12,15,16, with a predominance of 
stage T3 in our study (52.9%). Another finding deserving 
attention is the higher rate of malignization (17.6% in our 
study) vis-à-vis the rate mentioned in the literature (5%-
15%)17. Such fact may be attributed to the sample size as 
to referral of patients coming from other services.
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Table 6. Recurrence cases per approach and stage.
Approach
Krouse’s staging
I II III IV Total
Case Recur % Case Recur % Case Recur % Case Recur % Case Recur %
External - - - - - - 1 0 0 2 1 50 3 1 33.3
Combined - - - - - - 2 1 50 1 0 0 3 1 33.
Endoscopic - - - 5 1 20 6 1 16.6 - - - 11 2 18.1
Total - - - 5 1 20 9 2 22.2 3 1 33.3 17 4 23.5
Recur: Recurrence; %: percentage of recurrences per approach in each group.
After the first non-endoscopic approaches showed 
unacceptable recurrence rates, ranging between 20% all the 
way to 100%, they ended up being abandoned in favor of 
external approaches, which had been traditionally conside-
red the gold standard for the surgical treatment of inverted 
papillomas, since they provide the surgeon with good tumor 
exposure and satisfactory success rates in the postoperative. 
However, they were associated with significant intra and 
postoperative morbidity and longer times for recovery17. 
The development of the endoscope provided a series of 
advantages in comparison with the external approach, such 
as better visualization, better lighting and magnification of 
the operative field, including an angled view, which was not 
possible with the microscope. It provides for a better resection 
of viable tissue - not compromised by the tumor, causing less 
crust formation, less bleeding and less postoperative pain. 
After proving the efficacy of the endoscopic approach, the 
traditional approaches ended up losing their usefulness as 
treatment of choice for the inverted papilloma4,9,17-20.
In our study, all the patients classified as T2 were 
submitted to the endoscopic approach only. Of the nine 
patients who had stage T3 tumor, six were submitted to the 
endoscopic approach only, two to the combined approach 
and one to the external approach only. With this, we used 
the endoscopic approach only in 64% of the cases. These 
results suggest the consolidation of using the endoscope 
for the surgical treatment of the inverted papilloma, not 
only in less advanced stages as initially proposed, but also 
in more advanced stages. It is interesting to notice that the 
resection by piecemeal of the inverted papilloma, such 
as it is carried out in the endoscopic approach, does not 
seem to compromise control and recurrence rates when 
compared to open resection in a single block17.
One possible limitation of the endoscopic approach 
alone, is the access to lesions located in areas such as the 
frontal sinus or the anterior and inferior walls of the ma-
xillary sinus12. However, in a recent retrospective analysis 
involving 212 patients, only those lesions with extensive 
frontal and/or supraorbital involvement had to be submit-
ted to a combined approach. Even lesions involving the 
orbit or intracranial tissues could be treated through the 
endoscopic approach alone10.
Our recurrence rate was 23.5%, which is in agree-
ment with the rates published in the literature21 (varying 
between 20% and 47% in some series18,21). Notwithstand-
ing, when we assess the endoscopic approach only, the 
recurrence rate was lower -18.1%. This recurrence rate 
reduction in the endoscopic approach only, when com-
pared to the open procedure is in agreement with papers 
recently published in the international literature - 14%12,22 
on the first vs. 25% on the second22). However, there are 
very few papers describing the rates of recurrence vis-à-
-vis tumor stage, and when they are reported in function 
of tumor size and staging, an association between more 
advanced stages and a greater incidence of recurrence has 
yet to be better clarified4,9,13. In our study, we did not find 
a statistically significant correlation between recurrence 
and a higher tumor stage or malignization.
In a recent literature review, with 63 series of ca-
ses and an adequate methodology, with a total of 3,058 
patients)22, the authors identified 7.1% of synchronous 
carcinoma. The malignancy rate was 3.6%, and the mean 
time for such transformation was 52 months. The mean 
recurrence rates were 12.8% concerning the endoscopic 
access and 17% for the open procedure, increasing to 
34.2% for limited resections22.
In relation to postoperative complications, they 
happened to 17.6% of the patients in our study (septal 
perforation, oroantral fistulas and synechia, each one in 
different patients in the sample). In the literature, the rates 
vary according to the surgical approach - reaching up to 
42% in some papers18, and the most common complications 
were: epiphora, facial pain and nasal crusts2,18,23.
And finally, recent meta-analysis studies have shown 
lower recurrence rates associated with the endoscopic 
treatment alone when compared to the external approach 
(12 % vs. 20%)15,22, which supports the exclusive endosco-
pic treatment for inverted papillomas, even in advanced 
stages (when there is no extensive involvement of the 
frontal sinus and/or supraorbital involvement10), yielding 
lower postoperative recurrence rates and complications 
associated with the procedure - which was seen in the 
retrospective of our study.
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CONCLUSION
We described the profile of patients with inverted 
papilloma submitted to surgical treatment in our institution. 
Our study corroborates data from the national and inter-
national literature, proving the efficacy and safety of the 
endoscopic approach in the surgical treatment of inverted 
papillomas in more advanced stages.
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